AcrySof IOLs Found "Rotationally Stable" Compared to Tecnis

Article

In a retrospective comparison of post-implantation cases of residual refractive astigmatism, researches found AcrySof's intraocular lenses less likely to misalign.

ophthalmology, american academy of ophthalmology 2016, glaucoma, cataract, intraocular lens, iol, astigmatism

At the American Academy of Ophthalmology 2016 Meeting in Chicago, Brent Kramer presented the results of a compelling comparative analysis of the stability of two different makes of toric intraocular lenses (IOLs) to determine which was more likely to misalign.

In the presentation, Kramer identified two primary causes of residual refractive astigmatism after implantation: either the lens was of the wrong power or it was in the wrong place, whether (rarely) implanted at the incorrect axis or misaligned. Data was culled from Astigmatismfix.com, a “Toric Results Analyzer.” After reviewing data on nearly 8,000 cases from 2012 to 2015, his group found that 69% of cases involved lenses misaligned 5 degrees or more from their intended position.

When lenses were split by make, the two most widely common were from AcrySof and Tecnis. The data showed a great disparity in the likelihood to misalign, finding the Tecnis Toic IOL varieties almost 2.5 times more likely to do so. When misalignment did occur, the Tecnis lenses tended to migrate counter clockwise about two-thirds of the time, with their AcrySof counterparts showing no particular rotational bias.

This study group of implanted lenses that displayed a significant 5 degree or greater misalignment represents just a fraction of toric IOLs overall, less than 1 percent. Still, the study deemed the AcrySof Toric IOL “more rotationally stable” and “less likely than the Tecnis Toric IOL to cause residual astigmatism as a result of misorientation.”

Related Coverage

Directory of Military Eye Injuries Can Inform Policy and Care

Novel Mobile App May Help Doctors Diagnose Uveitis

"Ophthalmology Finally has a Simple Test that Can Detect HSV Infection.”

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.